These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 24875127)
1. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2. Yang M; Shan X; Zhou X; Qiu T; Zhu W; Ding Y; Shu Y; Liu P Anticancer Agents Med Chem; 2014; 14(6):884-91. PubMed ID: 24875127 [TBL] [Abstract][Full Text] [Related]
2. MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2. Wang T; Ge G; Ding Y; Zhou X; Huang Z; Zhu W; Shu Y; Liu P Chin Med J (Engl); 2014; 127(12):2357-62. PubMed ID: 24931256 [TBL] [Abstract][Full Text] [Related]
3. Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2. Zhuang M; Shi Q; Zhang X; Ding Y; Shan L; Shan X; Qian J; Zhou X; Huang Z; Zhu W; Ding Y; Cheng W; Liu P; Shu Y Tumour Biol; 2015 Apr; 36(4):2737-45. PubMed ID: 25492481 [TBL] [Abstract][Full Text] [Related]
4. Celastrol Inhibits the Proliferation and Decreases Drug Resistance of Cisplatin- Resistant Gastric Cancer SGC7901/DDP Cells. Zhan D; Ni T; Wang H; Lv M; Sunagawa M; Liu Y Anticancer Agents Med Chem; 2022; 22(2):270-279. PubMed ID: 34053427 [TBL] [Abstract][Full Text] [Related]
5. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891 [TBL] [Abstract][Full Text] [Related]
6. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway. Gu Y; Fei Z; Zhu R Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells. Jiang T; Dong P; Li L; Ma X; Xu P; Zhu H; Wang Y; Yang B; Liu K; Liu J; Xue J; Lv R; Su P; Kong G; Chang Y; Zhao C; Wang L Oncol Rep; 2017 Jul; 38(1):151-158. PubMed ID: 28534959 [TBL] [Abstract][Full Text] [Related]
8. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Zhu W; Shan X; Wang T; Shu Y; Liu P Int J Cancer; 2010 Dec; 127(11):2520-9. PubMed ID: 20162574 [TBL] [Abstract][Full Text] [Related]
9. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1. Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968 [TBL] [Abstract][Full Text] [Related]
10. miR‑138‑5p modulates the expression of excision repair cross‑complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin. Ning J; Jiao Y; Xie X; Deng X; Zhang Y; Yang Y; Zhao C; Wang H; Gu K Oncol Rep; 2019 Feb; 41(2):1131-1139. PubMed ID: 30535472 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-206 facilitates gastric cancer cell apoptosis and suppresses cisplatin resistance by targeting MAPK2 signaling pathway. Chen Z; Gao YJ; Hou RZ; Ding DY; Song DF; Wang DY; Feng Y Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):171-180. PubMed ID: 30657558 [TBL] [Abstract][Full Text] [Related]
12. Let-7b attenuates cisplatin resistance and tumor growth in gastric cancer by targeting AURKB. Han X; Zhang JJ; Han ZQ; Zhang HB; Wang ZA Cancer Gene Ther; 2018 Dec; 25(11-12):300-308. PubMed ID: 30237418 [TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis. Mei J; Liu G; Li R; Xiao P; Yang D; Bai H; Hao Y Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34821362 [TBL] [Abstract][Full Text] [Related]
14. miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells. Hu J; Fang Y; Cao Y; Qin R; Chen Q Dig Dis Sci; 2014 Feb; 59(2):336-45. PubMed ID: 24248414 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET. Zhang Z; Kong Y; Yang W; Ma F; Zhang Y; Ji S; Ma EM; Liu H; Chen Y; Hua Y Oncol Rep; 2016 Oct; 36(4):2391-7. PubMed ID: 27513895 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a. Cheng C; Qin Y; Zhi Q; Wang J; Qin C Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of miRNA-200c on chemotherapy-resistance and cell proliferation of gastric cancer SGC7901/DDP cells. Chen Y; Zuo J; Liu Y; Gao H; Liu W Chin J Cancer; 2010 Dec; 29(12):1006-11. PubMed ID: 21114921 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of CASC2 contributes to cisplatin resistance in gastric cancer by sponging miR-19a. Li Y; Lv S; Ning H; Li K; Zhou X; Xv H; Wen H Biomed Pharmacother; 2018 Dec; 108():1775-1782. PubMed ID: 30372881 [TBL] [Abstract][Full Text] [Related]
19. miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2. Zhu W; Zhu D; Lu S; Wang T; Wang J; Jiang B; Shu Y; Liu P Med Oncol; 2012 Mar; 29(1):384-91. PubMed ID: 21258880 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-101 induces apoptosis in cisplatin-resistant gastric cancer cells by targeting VEGF-C. Li G; Yang F; Gu S; Li Z; Xue M Mol Med Rep; 2016 Jan; 13(1):572-8. PubMed ID: 26573417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]